Warberg Asset Management’s Lixte Biotechnology Holdings, Inc. Warrants LIXTW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-35,906
Closed -$1.6K 192
2024
Q3
$1.6K Sell
35,906
-1,968
-5% -$88 ﹤0.01% 157
2024
Q2
$2.26K Sell
37,874
-3,001
-7% -$179 ﹤0.01% 171
2024
Q1
$2.05K Hold
40,875
﹤0.01% 167
2023
Q4
$1.53K Hold
40,875
﹤0.01% 173
2023
Q3
$2.58K Sell
40,875
-12,306
-23% -$775 ﹤0.01% 189
2023
Q2
$3.71K Hold
53,181
﹤0.01% 172
2023
Q1
$4.58K Buy
+53,181
New +$4.58K ﹤0.01% 187
2022
Q3
Sell
-12,000
Closed -$2K 275
2022
Q2
$2K Sell
12,000
-21,203
-64% -$3.53K ﹤0.01% 213
2022
Q1
$8K Buy
33,203
+15,269
+85% +$3.68K ﹤0.01% 186
2021
Q4
$8K Sell
17,934
-18,062
-50% -$8.06K ﹤0.01% 168
2021
Q3
$20K Buy
35,996
+21,642
+151% +$12K ﹤0.01% 157
2021
Q2
$11K Sell
14,354
-12,246
-46% -$9.39K ﹤0.01% 162
2021
Q1
$22K Buy
26,600
+13,599
+105% +$11.2K 0.01% 114
2020
Q4
$12K Buy
+13,001
New +$12K ﹤0.01% 103